SEARCH

SEARCH BY CITATION

References

  • 1
    Yox DP, Stokesberry H, Ritter RC. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol 1991; 260: R5038.
  • 2
    Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981; 213: 10367.
  • 3
    South EH, Ritter RC. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides 1988; 9: 60112.
  • 4
    Forster ER, Green T, Elliot M, Bremner A, Dockray GJ. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990; 258: G5526.
  • 5
    McMinn JE, Sindelar DK, Havel PJ, Schwartz MW. Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 2000; 141: 44428.
  • 6
    Stein LJ, Porte D Jr, Figlewicz DP, Woods SC. Effect of fasting interval on CCK-8 suppression of food intake in the baboon. Am J Physiol 1986; 250: R8515.
  • 7
    Gomez R, Navarro M, Ferrer B et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 2002; 22: 96127.
  • 8
    Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002; 136: 5507.
  • 9
    Di Marzo V, Goparaju SK, Wang L et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 8225.
  • 10
    Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, Dockray GJ. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 2004; 24: 270815.
  • 11
    McLaughlin PJ, Winston K, Swezey L et al. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 2003; 14: 5838.
  • 12
    Foltin RW, Brady JV, Fischman MW. Behavioural analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav 1986; 25: 57782.
  • 13
    Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Mot 2006; 18: 8318.
  • 14
    Lal S, McLaughlin J, Barlow J et al. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G729.
  • 15
    Little TJ, Gupta N, Case RM, Thompson DG, McLaughlin JT. Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans. Am J Physiol Regulat Integrat Comp Physiol 2009; 297: R6329.
  • 16
    Rinaldi-Carmona M, Barth F, Heaulme M et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994; 350: 2404.
  • 17
    Braden B, Adams S, Duan LP et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 1995; 108: 104855.
  • 18
    Turpault SKV, Lockwood GF. Rimonabant pharmacokinetics in healthy and obese subjects. Clin Pharmacol Therap 2006; 79: 50.
  • 19
    Canova A, Geary N. Intraperitoneal injections of nanogram CCK-8 doses inhibit feeding in rats. Appetite 1991; 17: 2217.
  • 20
    Dafny N, Gillman MA, Lichtigfeld FJ. Cholecystokinin: induced suppression of feeding in fed, fasting and hypothalamic island rats. Brain Res Bull 1988; 21: 22531.
  • 21
    Billington CJ, Levine AS, Morley JE. Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. Am J Physiol 1983; 245: R9206.
  • 22
    Burdyga G, Varro A, Dimaline R, Thompson DG, Dockray GJ. Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones. Neuroscience 2006; 137: 140515.
  • 23
    de Lartigue G, Dimaline R, Varro A, Dockray GJ. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci 2007; 27: 287682.
  • 24
    Brown SP, Brenowitz SD, Regehr WG. Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat Neurosci 2003; 6: 104857.
  • 25
    Johnstone AM, Faber P, Gibney ER et al. Effect of an acute fast on energy compensation and feeding behaviour in lean men and women. Internat J Obesity Related Metab Disorders 2002; 26: 16238.
  • 26
    Mars M, de Graaf C, de Groot LC, Kok FJ. Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am J Clin Nutr 2005; 81: 5707.
  • 27
    Corvilain B, Abramowicz M, Fery F et al. Effect of short-term starvation on gastric emptying in humans: relationship to oral glucose tolerance. Am J Physiol 1995; 269: G5127.
  • 28
    Bateman DN. Delta-9-tetrahydrocannabinol and gastric emptying. Br J Clin Pharmacol 1983; 15: 74951.
  • 29
    McCallum RW, Soykan I, Sridhar KR, Ricci DA, Lange RC, Plankey MW. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Therap 1999; 13: 7780.
  • 30
    Ameloot K, Janssen P, Scarpellini E et al. Endocannabinoid control of gastric sensorimotor function in man. Aliment Pharmacol Therap 2010; 31: 112331.
  • 31
    Di Marzo V, Capasso R, Matias I et al. The role of enocannabinoids in the regualtionof gastric emptying: alterations in mice fed a high-fat diet. Br J Parmacol 2008; 153: 1127280.
  • 32
    Vazuez-Roque MI, Camilleri M, Vella A et al. Association of genetic variation in cannabinoid mechanism and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Mot 2011; 23(7): 637-e257.
  • 33
    Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annual Rev Physiol 2006; 68: 279305.
  • 34
    Zittel TT, Rothenhofer I, Meyer JH, Raybould HE. Small intestinal capsaicin-sensitive afferents mediate feedback inhibition of gastric emptying in rats. Am J Physiol 1994; 267: G11425.
  • 35
    Holzer HH, Turkelson CM, Solomon TE, Raybould HE. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. Am J Physiol 1994; 267: G6259.
  • 36
    Schwartz GJ, Berkow G, McHugh PR, Moran TH. Gastric branch vagotomy blocks nutrient and cholecystokinin-induced suppression of gastric emptying [published errata appear in Am J Physiol 1993 Jun;264(6 Pt 2): section R following table of contents and 1993 Jun;264(6 Pt 3): section R following table of contents]. Am J Physiol 1993; 264: R6307.
  • 37
    McCann MJ, Verbalis JG, Stricker EM. Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats. J Autonomic Nervous Syst 1988; 23: 26572.
  • 38
    Moran TH, Baldessarini AR, Salorio CF, Lowery T, Schwartz GJ. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol 1997; 272: R124551.
  • 39
    Janberg T, Abrahamsson H, Jansson G, Martinson J. Gastric relaxatory response to feeding before and after vagotomy. Scand J Gastroenterol 1977; 12(2): 2258.
  • 40
    Troncon LE, Thompson DG, Ahluwalia NK, Barlow J, Heggie L. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 1995; 37(1): 1722.
  • 41
    Thompson DG, Ritchie HD, Wingate DL. Patterns of small intestinal motility in duodenal ulcer patients before and after vagotomy. Gut 1982; 23(6): 51723.
  • 42
    Schwizer W, Borovicka J, Kunz P et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997; 41: 5004.
  • 43
    Fried M, Erlacher U, Schwizer W et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991; 101: 50311.
  • 44
    Borovicka J, Kreiss C, Asal K et al. Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans. Am J Physiol 1996; 271: G44853.
  • 45
    Ward SJ, Raffa RB. Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring) 2011; 19: 132534.